For the first time in medical history, a hospital in Madrid has successfully treated seven patients who recently suffered heart attacks by using stem cells from donors, according to the hospital’s statement.
“Seven patients have already been operated on and they have progressed very well despite having suffered serious damage to their heart tissue,” the statement, published by Madrid’s Gregorio Maranon Hospital, said.
The hospital plans to treat 55 patients in the framework of the ongoing clinical trial which envisages a medical breakthrough in treating heart attacks. According to hospital officials, this is the first time cells coming from a genetically different person, or allogeneic cells, have been used to treat a myocardial infarction.
The injection of the cells is carried out through a coronary artery seven days after the patient has suffered a heart attack, so he is clinically stable and the cardio-repairing will be more effective. The new method limits the damage suffered after a heart episode, activating the regenerative capacity of the heart itself to produce new tissue.
To read more click here.
BSc (Hons) Microbiology
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.